Grandparenting
Masterpiece's The Durrells+Season Two; Enjoy Reading Gerald's Triology
During the recent UK broadcast, The Telegraph (London) was delighted to find that "Corfu was still sun-drenched, the titular family of lovable eccentrics remained in perpetual chaos and ... the tone was, as before, one of warm nostalgia and deep, abiding silliness." And The Guardian (London) hailed Season 2 as "sweet, and charming, and pretty, and funny…. [It's] that rather nice thing: Sunday night family drama entertainment." more »
Congressional Hearings, Bill Passed & Introduced: Trafficking Victims Protection Reauthorization Act, Needs of Children Considered, Extending Maternal, Infant & Early Childhood Home Visiting Program
A bill to provide for activities to increase the awareness and knowledge of health care providers and women with respect to ovarian and cervical cancer; A bill to modify the determination of earned income for purposes of the earned income credit and the child tax credit for individuals in the Hurricane Harvey and Hurricane Irma disaster areas. more »
Five Ways the Graham-Cassidy Proposal Puts Medicaid Coverage At Risk; Last-Ditch Effort By Republicans To Replace ACA: What You Need To Know
The Graham-Cassidy proposal to repeal and replace the Affordable Care Act (ACA) is reviving the federal health reform debate and could come up for a vote in the Senate in the next two weeks before the budget reconciliation authority expires on September 30. The Graham-Cassidy proposal goes beyond the American Health Care Act (AHCA) passed by the House in May and the Better Care Reconciliation Act (BCRA) that failed in the Senate in July. The Graham-Cassidy proposal revamps and cuts Medicaid, redistributes federal funds across states, and eliminates coverage for millions of poor Americans. more »
FDA Commissioner Gottlieb, MD On the Continued Efforts to Promote Safe Adoption of Medication-assisted Treatment for Opioid Addiction
"Today, the FDA issued a Drug Safety Communication alerting health care providers and patients of the increased risk of serious side effects when combining these particular MAT drugs with benzodiazepines – often prescribed to treat anxiety, insomnia, or other conditions – and how to address these risks while continuing to maintain patients on MAT. In addition, the FDA also recently strengthened labeling for the MAT drug buprenorphine to emphasize that patients may require treatment indefinitely and should continue treatment for as long as they benefit and as long as the use of MAT contributes to their intended treatment goals." more »
